Research America hosts a webcast that will provide an overview of the most promising scientific approaches underway to create vaccines, treat COVID-19, and prevent infection.

Stat’s Matthew Herper will talk with Diana Brainard, senior vice president, HIV and Emerging Viral Infections from Gilead Sciences. They’ll dive into the steps being taken to develop antiviral treatments and break down the big questions around time frame, testing, and more.

Experts will explore how data from testing can provide a clear picture of who has been infected, who can safely return to work, and how the virus is spreading. They will also discuss how to ensure equitable access to testing, particularly among communities of color, the uninsured and underinsured, and people with disabilities.

Experts from Johns Hopkins will share the state of Maryland’s best practices for addressing a number of challenges – preventing hospitalization, ensuring there’s enough PPE and that staff are well-trained, and easing the toll of loneliness and isolation.  

Scott Whitaker, president and CEO of AdvaMed, the world’s largest medical technology association, will hold a press conference to discuss the current state of testing for the COVID-19 virus and what the medical technology industry – which creates and manufactures these tests – is doing to meet the unprecedented demand presented by this crisis. In addition, Whitaker will announce the latest steps the industry is taking to help ensure testing capacity is sufficient to allow the U.S. economy to safely reopen.